• Irrespective if the results are positive or negative.
• At the beginning of the study (information).
• At the end of the study (results).
• At multiple platforms like public registries:

_{- US: clinicaltrials.gov}

_{- EU: Clinical Trials in the European Union - EMA euclinicaltrials.eu}

  _{Clinical Trails Information System (CTIS)}

_{- This website}

• After the data has been ”redacted”. (Redaction is a process to ensure that any personal data and/or commercially confidential information is removed and that the published document follows regulatory guidance, data protection laws and company policies.)

• With researchers who have interest in detailed datasets.
• In accordance with international and national laws and guidelines. Key  references here are:

_{- European Union Legislation}

_{- US Food and Drug Administration Acts}

_{- IFPMEA Joint Position}

_{- WMA Declaration of Helsinki}